跳至主要内容
临床试验/NL-OMON49762
NL-OMON49762尚未招募2 期

Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIAL - TNT-OES-1 TRIA

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - adenocarcinoma of the esophagus or gastro-esophageal junction with limited
  • but distant retroperitoneal and/or supraclavicular lymphatic dissemination
  • and/or maximum of 4 oligo metastases
  • - resectable primary esophageal tumor
  • - age 18-75
  • ECOG performance status 0-1
  • No prior radiotherapy or chemotherapy

排除标准

  • Polyneuropathy grade 1 or higher
  • Secondary primary cancer
  • Clinically significant cardiac disease (e.g. symptomatic coronary artery
  • disease or myocardial infarction within last 12 months)
  • Clinically significant pulmonary disease (Forced expiratory volume in 1 second

研究者

相似试验